Pediatric Infection and Vaccine

  • 제27권3호
  • /
  • Pages.158-170
  • /
  • 2020
  • /
  • 2384-1079(pISSN)
  • /
  • 2384-1087(eISSN)
대한소아감염학회 (The Korean Society of Pediatric Infectious Diseases)
권호 표지
DOI QR코드

DOI QR Code

소아 Clostridioides difficile 감염의 발생률 및 임상양상

Incidence and Characteristics of Clostridioides difficile Infection in Children

  • 정희라 (연세대학교 의과대학 소아과학교실, 세브란스 어린이병원 소아청소년과) ;
  • 강지만 (연세대학교 의과대학 소아과학교실, 세브란스 어린이병원 소아청소년과) ;
  • 안종균 (연세대학교 의과대학 소아과학교실, 세브란스 어린이병원 소아청소년과)
  • Jeong, Heera (Department of Pediatrics, Severance Children's Hospital, Yonsei University College of Medicine) ;
  • Kang, Ji-Man (Department of Pediatrics, Severance Children's Hospital, Yonsei University College of Medicine) ;
  • Ahn, Jong Gyun (Department of Pediatrics, Severance Children's Hospital, Yonsei University College of Medicine)
  • 투고 : 2020.08.22
  • 심사 : 2020.10.29
  • 발행 : 2020.12.25
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

목적: 이 연구의 목적은 우리 나라 소아에서 Clostridioides difficile 감염(CDI)의 발생률 및 임상양상을 확인하는 것이다. 방법: 2009년 1월부터 2018년 12월까지 세브란스 어린이병원에 입원한 2세 이상 18세 미만의 환자 중 CDI로 진단된 환자들의 의무기록을 확인하였고 환자를 세 군(community acquired [CA], community onset-health care facility associated [CO-HCFA], and health care facility onset [HO] CDI)으로 나누어 임상양상을 비교하였다. 결과: 2009년부터 2018년까지 CDI유병률은 입원환자 10,000명당 1.00명에서 10.01명까지 증가하였다(P<0.001). HO CDI 군은 CA CDI 군에 비해 수술(40.4% vs. 0.0%, P=0.001)과 악성종양(27.7% vs. 0.0%, P=0.027)이 선행된 경우가 많았고 CDI 진단 전 항생제의 사용 빈도(97.9% vs. 31.3%, P<0.001) 및 항생제 개수의 중앙값이(2 vs. 0, P<0.001) 높았으며 CDI진단 이후 재원일수(13일 vs. 5일, P=0.008) 가 길었다. CO-HCFA 군은 CA CDI 군보다 연령의 중앙값이 낮았고(5세 vs. 13세, P=0.012) 악성종양이 선행된 경우가 많았다(30.8% vs. 0.0%, P=0.030). CA CDI 군은 HO CDI 군에 비해 복통(56.3% vs. 10.6%, P=0.001)과 혈변(50.0% vs. 10.6%, P =0.002)이 동반된 빈도가 높았고, 염증성 장질환이 동반된 경우가 많았으며(68.8% vs. 2.1%, P =0.001), 치료로서 정주 metronidazole을 더 자주 사용하였다(37.5% vs. 2.1%, P =0.001). 결론: 국내 소아의 CDI 발생률이 증가되고 있어 이에 대해 경각심을 가지고 역학과 임상적 특징을 파악하는 것은 병원 감염관리를 위하여 중요하다.

Purpose: We evaluated the incidence and characteristics of Clostridioides difficile infection (CDI) in Korean children. Methods: Medical records of patients aged 2-18 years and diagnosed with CDI at a tertiary hospital between 2009 and 2018 were analyzed. The patients were classified into three CDI groups: community-acquired (CA), community onset-health care facility-associated (CO-HCFA), and healthcare facility onset (HO). Results: The incidence of CDI increased from 1.00 to 10.01 cases per 10,000 admissions from 2009 to 2018 (P<0.001). As compared to the CA group, the HO group had a higher frequency of operation and malignancy as predisposing factors (40.4% vs. 0.0%, P=0.001; and 27.7% vs. 0.0%, P=0.027, respectively), frequency and number of previous antibiotic use (97.9% vs. 31.3%, P<0.001; and 2 vs. 0, P<0.001, respectively), and median postdiagnosis hospital stay (13 vs. 5 days, P=0.008). The CO-HCFA group had a lower median age and higher frequency of malignancy than the CA group (5 vs. 13 years, P=0.012; and 30.8% vs. 0.0%, P=0.030, respectively). As compared to the HO group, the CA group had a higher frequency of abdominal pain and hematochezia (56.3% vs. 10.6%, P=0.001; and 50.0% vs. 10.6%, P=0.002, respectively), inflammatory bowel disease (68.8% vs. 2.1%, P=0.001), and intravenous metronidazole treatment (37.5% vs. 2.1%, P=0.001). Conclusions: With the increasing incidence of pediatric CDI, awareness regarding its epidemiology and clinical characteristics is important to manage nosocomial infections.

키워드

참고문헌

  1. Burke KE, Lamont JT. Clostridium difficile infection: a worldwide disease. Gut Liver 2014;8:1-6. https://doi.org/10.5009/gnl.2014.8.1.1
  2. Gil JH, Seo JW. Clostridium difficile infections in children. Ewha Med J 2011;34:3-12.
  3. Zhang S, Palazuelos-Munoz S, Balsells EM, Nair H, Chit A, Kyaw MH. Cost of hospital management of Clostridium difficile infection in United States-a meta-analysis and modelling study. BMC Infect Dis 2016;16:447. https://doi.org/10.1186/s12879-016-1786-6
  4. Heister T, Wolkewitz M, Hehn P, Wolff J, Dettenkofer M, Grundmann H, et al. Costs of hospital-acquired Clostridium difficile infections: an analysis on the effect of time-dependent exposures using routine and surveillance data. Cost Eff Resour Alloc 2019;17:16. https://doi.org/10.1186/s12962-019-0184-5
  5. Lessa FC, Mu Y, Bamberg WM, Beldavs ZG, Dumyati GK, Dunn JR, et al. Burden of Clostridium difficile infection in the United States. N Engl J Med 2015;372:825-34. https://doi.org/10.1056/NEJMoa1408913
  6. Lees EA, Miyajima F, Pirmohamed M, Carrol ED. The role of Clostridium difficile in the paediatric and neonatal gut - a narrative review. Eur J Clin Microbiol Infect Dis 2016;35:1047-57. https://doi.org/10.1007/s10096-016-2639-3
  7. Enoch DA, Butler MJ, Pai S, Aliyu SH, Karas JA. Clostridium difficile in children: colonisation and disease. J Infect 2011;63:105-13. https://doi.org/10.1016/j.jinf.2011.05.016
  8. Jangi S, Lamont JT. Asymptomatic colonization by Clostridium difficile in infants: implications for disease in later life. J Pediatr Gastroenterol Nutr 2010;51:2-7. https://doi.org/10.1097/MPG.0b013e3181d29767
  9. Stark PL, Lee A, Parsonage BD. Colonization of the large bowel by Clostridium difficile in healthy infants: quantitative study. Infect Immun 1982;35:895-9. https://doi.org/10.1128/iai.35.3.895-899.1982
  10. McDonald LC, Gerding DN, Johnson S, Bakken JS, Carroll KC, Coffin SE, et al. Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clin Infect Dis 2018;66:987-94. https://doi.org/10.1093/cid/ciy149
  11. Pepin J, Valiquette L, Alary ME, Villemure P, Pelletier A, Forget K, et al. Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity. CMAJ 2004;171:466-72. https://doi.org/10.1503/cmaj.1041104
  12. McFarland LV. Update on the changing epidemiology of Clostridium difficile-associated disease. Nat Clin Pract Gastroenterol Hepatol 2008;5:40-8. https://doi.org/10.1038/ncpgasthep1029
  13. Borali E, De Giacomo C. Clostridium difficile infection in children: a review. J Pediatr Gastroenterol Nutr 2016;63:e130-40. https://doi.org/10.1097/MPG.0000000000001264
  14. Zilberberg MD, Tillotson GS, McDonald C. Clostridium difficile infections among hospitalized children, United States, 1997-2006. Emerg Infect Dis 2010;16:604-9. https://doi.org/10.3201/eid1604.090680
  15. Byun TJ, Han DS, Ahn SB, Cho HS, Kim TY, Eun CS, et al. Clinical characteristics and changing epidemiology of Clostridium difficile-associated disease (CDAD). Korean J Gastroenterol 2009;54:13-9. https://doi.org/10.4166/kjg.2009.54.1.13
  16. Lee JH, Lee SY, Kim YS, Park SW, Park SW, Jo SY, et al. The incidence and clinical features of Clostridium difficile infection; single center study. Korean J Gastroenterol 2010;55:175-82. https://doi.org/10.4166/kjg.2010.55.3.175
  17. Kim H, Lee Y, Moon HW, Lim CS, Lee K, Chong Y. Emergence of Clostridium difficile ribotype 027 in Korea. Korean J Lab Med 2011;31:191-6.
  18. McDonald LC, Coignard B, Dubberke E, Song X, Horan T, Kutty PK, et al. Recommendations for surveillance of Clostridium difficile-associated disease. Infect Control Hosp Epidemiol 2007;28:140-5. https://doi.org/10.1086/511798
  19. Kim SJ, Kim H, Kim MS, Koh E, Kim CK, Jeong SH, et al. Evaluation of rapid assay (Tox A/B Quik Chek) for the detection of Clostridium difficile toxins A and B. Korean J Clin Microbiol 2008;11:112-6. https://doi.org/10.5145/KJCM.2008.11.2.112
  20. Song PH, Min JH, Kim YS, Jo SY, Kim EJ, Lee KJ, et al. Rapid and accurate diagnosis of Clostridium difficile infection by real-time polymerase chain reaction. Intest Res 2018;16:109-15. https://doi.org/10.5217/ir.2018.16.1.109
  21. Kim J, Smathers SA, Prasad P, Leckerman KH, Coffin S, Zaoutis T. Epidemiological features of Clostridium difficile-associated disease among inpatients at children's hospitals in the United States, 2001-2006. Pediatrics 2008;122:1266-70. https://doi.org/10.1542/peds.2008-0469
  22. Kim B, Yang H, Jeong S, Lee K, Kim J, Ko J, et al. Clostridium difficile colitis in childhood: associated antibiotics. Korean J Pediatr Gastroenterol Nutr 2002;5:143-9. https://doi.org/10.5223/kjpgn.2002.5.2.143
  23. Park JH, Kang KJ, Kang YN, Kim AS, Hwang JB. Pseudomembranous colitis in children: experience of a university hospital in Korea. Korean J Pediatr 2010;53:184-9. https://doi.org/10.3345/kjp.2010.53.2.184
  24. Sandora TJ, Fung M, Flaherty K, Helsing L, Scanlon P, Potter-Bynoe G, et al. Epidemiology and risk factors for Clostridium difficile infection in children. Pediatr Infect Dis J 2011;30:580-4. https://doi.org/10.1097/INF.0b013e31820bfb29
  25. Centers for Disease Control and Prevention (CDC). Surveillance for community-associated Clostridium difficile--Connecticut, 2006. MMWR Morb Mortal Wkly Rep 2008;57:340-3.
  26. Cho HJ, Ryoo E, Sun YH, Cho KH, Son DW, Tchah H. Epidemiology and clinical characteristics of Clostridium difficile-associated disease in children: comparison between community-and hospital-acquired infections. Korean J Pediatr Gastroenterol Nutr 2010;13:146-53. https://doi.org/10.5223/kjpgn.2010.13.2.146
  27. Pascarella F, Martinelli M, Miele E, Del Pezzo M, Roscetto E, Staiano A. Impact of Clostridium difficile infection on pediatric inflammatory bowel disease. J Pediatr 2009;154:854-8. https://doi.org/10.1016/j.jpeds.2008.12.039